RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000084.xml
Synthesis 2006(8): 1289-1294
DOI: 10.1055/s-2006-926415
DOI: 10.1055/s-2006-926415
PAPER
© Georg Thieme Verlag Stuttgart · New York
Efficient Construction of a Doubly Functionalized Trisoxazole Derivative Relevant to the Synthesis of the Novel Telomerase Inhibitor Telomestatin and its Analogues
Weitere Informationen
Received
4 July 2005
Publikationsdatum:
28. März 2006 (online)
Publikationsverlauf
Publikationsdatum:
28. März 2006 (online)
![](https://www.thieme-connect.de/media/synthesis/200608/lookinside/thumbnails/10.1055-s-2006-926415-1.jpg)
Abstract
An efficient construction of a suitably functionalized trisoxazole derivative related to telomestatin was developed from l-serine, which involved three sequential oxazoline cyclization-oxidation steps in an overall yield of 11% in a linear sequence of twelve steps.
Key words
heterocycles - chiral pool - oxidations - peptides - oxazoles
- For reviews see:
-
1a
Pattenden G. J. Heterocycl. Chem. 1992, 29: 607 -
1b
Wipf P. Chem. Rev. 1995, 95: 2115 -
1c
Faulkner D. Nat. Prod. Rep. 2002, 29: 1 -
1d
Yeh VSC. Tetrahedron 2004, 60: 11995 - For some examples, see:
-
2a
Gonzalez MA.Pattenden G. Angew. Chem. Int. Ed. 2003, 42: 1255 -
2b
Krebs O.Taylor RJK. Org. Lett. 2005, 7: 1063 -
2c
Bagley MC.Chapaneri K.Dale JW.Xiong X.Bower J. J. Org. Chem. 2005, 70: 1389 -
2d
Bagley MC.Bashford KE.Hesketh CL.Moody CJ. J. Am. Chem. Soc. 2000, 122: 3301 -
2e
Mann E.Kessler H. Org. Lett. 2003, 5: 4567 -
2f
Burgett AWG.Li Q.Wei Q.Harran PG. Angew. Chem. Int. Ed. 2003, 42: 4961 - 3
Shin-Ya K.Weirzba K.Matsuo K.Ohtani T.Yamada Y.Furihata K.Hayakawa Y.Seto HJ. J. Am. Chem. Soc. 2001, 123: 1262 - 4
Kim MY.Vankayalapati H.Shin-Ya K.Weirzba K.Hurley LH. J. Am. Chem. Soc. 2002, 124: 2098 -
5a
Kim MY.Gleason-Guzman M.Izbicka E.Nishioka D.Hurley LH. Cancer Res. 2003, 63: 3247 -
5b
Nakajima A.Tauchi T.Sashida G.Sumi M.Abe K.Yamamoto K.Ohyashiki JH.Ohyashiki K. Leukemia 2003, 17: 560 -
5c
Sumi M.Tauchi T.Sashida G.Nakajima A.Gotoh A.Shin-Ya K.Ohyashiki JH.Ohyashiki K. Int. J. Oncol. 2004, 24: 1481 -
5d
Shamma MA.Reis RJS.Li C.Koley H.Hurley LH.Andersson KC.Munshi NC. Clin. Cancer Res. 2004, 10: 770 -
6a
Garner P.Park JM. J. Org. Chem. 1987, 52: 2361 -
6b
McKillop A.Taylor RJK.Watson RJ.Lewis N. Synthesis 1994, 31 -
7a
Gant TG.Meyers AI. Tetrahedron 1994, 50: 2297 -
7b
Wipf P.Miller CP.Hayes GB. Tetrahedron 1998, 54: 6987 -
7c
Evans DA.Peterson GS.Johnson JS.Barnes DM.Campos KR.Woerpel KA. J. Org. Chem. 1998, 63: 4541 -
7d
Rajaram S.Sigman MS. Org. Lett. 2002, 4: 3399 -
7e
DeRoy PL.Charette AB. Org. Lett. 2003, 5: 4163 -
8a
Philips AJ.Uto Y.Wipf P.Reno MJ.Williams DR. Org. Lett. 2000, 2: 1165 -
8b
Burrell G.Evans JM.Jones GE.Stemp G. Tetrahedron Lett. 1990, 31: 3649 -
8c
Lafargue P.Guenot P.Lellouche J.-P. Heterocycles 1995, 41: 947 -
9a
Williams DR.Brooks DA.Berliner MA.Reeves JT. J. Am. Chem. Soc. 1999, 121: 4924 -
9b
Williams DR.Kiryanov AA.Emde U.Clark MP.Berliner MA.Reeves JT. Angew. Chem. Int. Ed. 2003, 42: 1258 -
9c
Wipf P.Uto Y. J. Org. Chem. 2000, 65: 1037 - 10
Boden CDJ.Pattenden G.Ye T. Synlett 1995, 417 - 11
Williams DR.Lowder PD.Gu Y.-G.Brooks DA. Tetrahedron Lett. 1997, 38: 331 - 12
Chattopadhyay SK.Kempson J.McNeil A.Pattenden G.Reader M.Rippon DE.Waite D. J. Chem. Soc., Perkin Trans. 1 2000, 2415 -
14a
Knight DW.Pattenden G.Rippon DE. Synlett 1990, 36 -
14b
Doyle KJ.Moody CJ. Tetrahedron 1994, 50: 3761 -
14c
Yoo S.-K. Tetrahedron Lett. 1992, 33: 2159 -
14d
Chattopadhyay SK.Pattenden G. Synlett 1997, 1342 -
14e
Panek JS.Beresis RT. J. Org. Chem. 1996, 61: 6496
References
Although the chirality of serine is destroyed in subsequent steps we preferred to use l-serine to avoid diastereomeric problems.